{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:13:41Z","timestamp":1794647621972,"version":"4.9.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ningbo Top Medical and Health Research Program","award":["No. 2022020405"],"award-info":[{"award-number":["No. 2022020405"]}]},{"name":"Medical and Health Technology Plan Projects of Zhejiang","award":["2024YK1568"],"award-info":[{"award-number":["2024YK1568"]}]},{"name":"Ningbo Medical and Health Brand Discipline","award":["PPXK2024-06"],"award-info":[{"award-number":["PPXK2024-06"]}]},{"name":"Ningbo Medical and Health Brand Discipline","award":["PPXK2024-06"],"award-info":[{"award-number":["PPXK2024-06"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["Nos. 82370310 and 82270314"],"award-info":[{"award-number":["Nos. 82370310 and 82270314"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["Nos. 82370310 and 82270314"],"award-info":[{"award-number":["Nos. 82370310 and 82270314"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007219","name":"Shanghai Natural Science Foundation","doi-asserted-by":"crossref","award":["No. 22ZR147900"],"award-info":[{"award-number":["No. 22ZR147900"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Pediatric heart failure (HF) research remains in its infancy partly due to the lack of neonatal rat\/mouse models of HF. The aim of the study is to introduce a neonatal rat\/mouse model of right ventricular (RV) pressure overload (RVPO), a significant cause of pediatric HF, and to uncover the molecular features of RVPO-induced RV hypertrophy and fibrosis\u2014the two most important transitional pathological states between normal and dysfunctional RV. Neonatal rat\/mouse model of RVPO was established by pulmonary artery banding (PAB) surgery on postnatal day 1(P1) and confirmed by echocardiography and morphological examination on P7. Bulk RNA and single-cell RNA sequencing was performed on RV tissues, along with bulk RNA sequencing on RV cardiomyocytes, to screen a range of key genes and signaling pathways that are upregulated and that play critical roles in adult hypertrophy and fibrosis. The sequencing results were further verified by qRT-PCR and histological staining. Most of the pathways and associated genes, such as oxidative stress, inflammation, phosphodiesterase, proteasome, protein kinase, transforming growth factor, and angiotensin were not changed or downregulated in the neonatal RVPO model. This study reveals the unique features of hypertrophy and fibrosis in the neonatal RV in response to pressure overload, which partly explains why adult-effective anti-HF drugs fail to treat pediatric HF. More importantly, single-cell RNA sequencing data of the neonatal RV with pressure overload were documented, providing an important reference for future basic or clinical investigations on pediatric RV failure.<\/jats:p>","DOI":"10.1038\/s41598-025-01427-y","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T15:16:11Z","timestamp":1747754171000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The unique hypertrophic and fibrotic features of neonatal right ventricle in response to pressure overload"],"prefix":"10.1038","volume":"15","author":[{"given":"Yingying","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lincai","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sixie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peisen","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifa","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"issue":"19","key":"1427_CR1","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/j.jacc.2022.03.339","volume":"79","author":"KP Daly","year":"2022","unstructured":"Daly, K. P. & Zuckerman, W. A. The burden of pediatric heart failure that Lies just under the surface. J. Am. Coll. Cardiol. 79 (19), 1929\u20131931. https:\/\/doi.org\/10.1016\/j.jacc.2022.03.339 (2022).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"19","key":"1427_CR2","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.jacc.2022.03.336","volume":"79","author":"S Amdani","year":"2022","unstructured":"Amdani, S. et al. Burden of pediatric heart failure in the united States. J. Am. Coll. Cardiol. 79 (19), 1917\u20131928. https:\/\/doi.org\/10.1016\/j.jacc.2022.03.336 (2022).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1427_CR3","doi-asserted-by":"publisher","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E., Jemal, A. & Cancer statistics. CA Cancer J Clin. 72(1), 7\u201333. https:\/\/doi.org\/10.3322\/caac.21708 (2022).","DOI":"10.3322\/caac.21708"},{"issue":"7","key":"1427_CR4","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.healun.2018.02.009","volume":"37","author":"WT Mahle","year":"2018","unstructured":"Mahle, W. T. et al. Pediatric heart network investigators. heart failure after the Norwood procedure: an analysis of the single ventricle reconstruction trial. J. Heart Lung Transpl. 37 (7), 879\u2013885. https:\/\/doi.org\/10.1016\/j.healun.2018.02.009 (2018).","journal-title":"J. Heart Lung Transpl."},{"issue":"10","key":"1427_CR5","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.healun.2019.08.002","volume":"38","author":"JW Rossano","year":"2019","unstructured":"Rossano, J. W. et al. International society for heart and lung transplantation. The international thoracic organ transplant registry of the international society for heart and lung transplantation. Twenty-second pediatric heart transplantation report \u2013\u20092019; focus theme: donor and recipient size match. J. Heart Lung Transpl. 38 (10), 1028\u20131041. https:\/\/doi.org\/10.1016\/j.healun.2019.08.002 (2019).","journal-title":"J. Heart Lung Transpl."},{"issue":"6","key":"1427_CR6","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1161\/CIRCRESAHA.116.308996","volume":"120","author":"RB Hinton","year":"2017","unstructured":"Hinton, R. B. & Ware, S. M. Heart failure in pediatric patients with congenital heart disease. Circ. Res. 120 (6), 978\u2013994. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.308996 (2017).","journal-title":"Circ. Res."},{"key":"1427_CR7","doi-asserted-by":"publisher","unstructured":"Smeets, N. J. L. et al. Pharmacology of enalapril in children: a review. Drug Discov Today. Aug 21:S1359-6446(20)30336-6. (2020). https:\/\/doi.org\/10.1016\/j.drudis.2020.08.005","DOI":"10.1016\/j.drudis.2020.08.005"},{"issue":"3","key":"1427_CR8","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1161\/CIRCULATIONAHA.112.135392","volume":"127","author":"T van der Bom","year":"2013","unstructured":"van der Bom, T. et al. Effect of Valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial. Circulation 127 (3), 322\u2013330. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.135392 (2013).","journal-title":"Circulation"},{"key":"1427_CR9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1161\/CIRCULATIONAHA.109.927988","volume":"122","author":"DT Hsu","year":"2010","unstructured":"Hsu, D. T. et al. Enalapril in infants with single ventricle: results of a multicenter randomized trial. Circulation 122, 333\u2013340 (2010).","journal-title":"Circulation"},{"issue":"4","key":"1427_CR10","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/biology13040234","volume":"13","author":"S Zheng","year":"2024","unstructured":"Zheng, S. & Ye, L. Hemodynamic melody of postnatal cardiac and pulmonary development in children with congenital heart diseases. Biology (Basel). 13 (4), 234. https:\/\/doi.org\/10.3390\/biology13040234 (2024).","journal-title":"Biology (Basel)"},{"issue":"3","key":"1427_CR11","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.healun.2023.10.009","volume":"43","author":"D Li","year":"2024","unstructured":"Li, D. et al. A surgical mouse model of neonatal right ventricular outflow tract obstruction by pulmonary artery banding. J. Heart Lung Transpl. 43 (3), 496\u2013507. https:\/\/doi.org\/10.1016\/j.healun.2023.10.009 (2024).","journal-title":"J. Heart Lung Transpl."},{"issue":"12","key":"1427_CR12","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.jacc.2018.12.076","volume":"73","author":"J Sanz","year":"2019","unstructured":"Sanz, J., S\u00e1nchez-Quintana, D., Bossone, E., Bogaard, H. J. & Naeije, R. Anatomy, function, and dysfunction of the right ventricle: JACC State-of-the-Art review. J. Am. Coll. Cardiol. 73 (12), 1463\u20131482. https:\/\/doi.org\/10.1016\/j.jacc.2018.12.076 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"1427_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.118.035326","volume":"139","author":"S Andersen","year":"2019","unstructured":"Andersen, S., Nielsen-Kudsk, J. E., Vonk Noordegraaf, A. & de Man, F. S. Right Ventricular Fibros. Circulation ;139(2):269\u2013285. doi: https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.035326. (2019).","journal-title":"Right Ventricular Fibros. Circulation"},{"issue":"12","key":"1427_CR14","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1093\/cvr\/cvab299","volume":"118","author":"RF Videira","year":"2022","unstructured":"Videira, R. F. et al. The adult heart requires baseline expression of the transcription factor Hand2 to withstand right ventricular pressure overload. Cardiovasc. Res. 118 (12), 2688\u20132702. https:\/\/doi.org\/10.1093\/cvr\/cvab299 (2022).","journal-title":"Cardiovasc. Res."},{"issue":"7","key":"1427_CR15","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.jacbts.2022.02.018","volume":"7","author":"M M\u00fcller","year":"2022","unstructured":"M\u00fcller, M. et al. Right heart failure in mice upon pressure overload is promoted by mitochondrial oxidative stress. JACC Basic. Transl Sci. 7 (7), 658\u2013677. https:\/\/doi.org\/10.1016\/j.jacbts.2022.02.018 (2022).","journal-title":"JACC Basic. Transl Sci."},{"key":"1427_CR16","doi-asserted-by":"publisher","unstructured":"Russo, I. et al. Extracellular matrix [preprint].stability and chronic [preprint].flammation underlie maladaptive [preprint].ght ventricular [preprint].essure overload [preprint].modeling and failure [preprint]. male mice. BioRxiv [Preprint]. 2024 Apr 5:2024.04.03.588013. https:\/\/doi.org\/10.1101\/2024.04.03.588013 (2024).","DOI":"10.1101\/2024.04.03.588013"},{"issue":"3","key":"1427_CR17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1161\/CIRCULATIONAHA.106.655266","volume":"116","author":"J Nagendran","year":"2007","unstructured":"Nagendran, J. et al. Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute Inhibition of phosphodiesterase type 5 improves contractility. Circulation 116 (3), 238\u2013248. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.655266 (2007).","journal-title":"Circulation"},{"issue":"2","key":"1427_CR18","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/cvr\/cvz103","volume":"116","author":"T Heitmeier","year":"2020","unstructured":"Heitmeier, T. et al. Altered proteasome function in right ventricular hypertrophy. Cardiovasc. Res. 116 (2), 406\u2013415. https:\/\/doi.org\/10.1093\/cvr\/cvz103 (2020).","journal-title":"Cardiovasc. Res."},{"issue":"17","key":"1427_CR19","doi-asserted-by":"publisher","first-page":"6421","DOI":"10.3390\/ijms21176421","volume":"21","author":"E Pena","year":"2020","unstructured":"Pena, E., Brito, J., El Alam, S. & Siques, P. Oxidative stress, kinase activity and inflammatory implications in right ventricular hypertrophy and heart failure under hypobaric hypoxia. Int. J. Mol. Sci. 21 (17), 6421. https:\/\/doi.org\/10.3390\/ijms21176421 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"1427_CR20","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1165\/rcmb.2016-0374OC","volume":"57","author":"B Kojonazarov","year":"2017","unstructured":"Kojonazarov, B. et al. p38 MAPK Inhibition improves heart function in Pressure-Loaded right ventricular hypertrophy. Am. J. Respir Cell. Mol. Biol. 57 (5), 603\u2013614. https:\/\/doi.org\/10.1165\/rcmb.2016-0374OC (2017).","journal-title":"Am. J. Respir Cell. Mol. Biol."},{"issue":"4","key":"1427_CR21","doi-asserted-by":"publisher","first-page":"e000965","DOI":"10.1161\/JAHA.114.000965","volume":"3","author":"NK Kapur","year":"2014","unstructured":"Kapur, N. K. et al. Reducing endoglin activity limits calcineurin and TRPC-6 expression and improves survival in a mouse model of right ventricular pressure overload. J. Am. Heart Assoc. 3 (4), e000965. https:\/\/doi.org\/10.1161\/JAHA.114.000965 (2014).","journal-title":"J. Am. Heart Assoc."},{"issue":"7","key":"1427_CR22","doi-asserted-by":"publisher","first-page":"e007928","DOI":"10.1161\/JAHA.117.007928","volume":"7","author":"M Sun","year":"2018","unstructured":"Sun, M. et al. Experimental right ventricular hypertension induces regional \u03b21-Integrin-Mediated transduction of hypertrophic and profibrotic right and left ventricular signaling. J. Am. Heart Assoc. 7 (7), e007928. https:\/\/doi.org\/10.1161\/JAHA.117.007928 (2018).","journal-title":"J. Am. Heart Assoc."},{"issue":"8","key":"1427_CR23","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1161\/hc3401.093149","volume":"104","author":"JL Rouleau","year":"2001","unstructured":"Rouleau, J. L. et al. Cardioprotective effects of Ramipril and Losartan in right ventricular pressure overload in the Rabbit: importance of Kinins and influence on angiotensin II type 1 receptor signaling pathway. Circulation 104 (8), 939\u2013944. https:\/\/doi.org\/10.1161\/hc3401.093149 (2001).","journal-title":"Circulation"},{"issue":"5","key":"1427_CR24","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.pcl.2020.06.004","volume":"67","author":"K Watanabe","year":"2020","unstructured":"Watanabe, K. & Shih, R. Update of pediatric heart failure. Pediatr. Clin. North. Am. 67 (5), 889\u2013901. https:\/\/doi.org\/10.1016\/j.pcl.2020.06.004 (2020).","journal-title":"Pediatr. Clin. North. Am."},{"issue":"6","key":"1427_CR25","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/eurheartj\/ehaa554","volume":"42","author":"H Baumgartner","year":"2021","unstructured":"Baumgartner, H. et al. 2020 ESC guidelines for the management of adult congenital heart disease. Eur. Heart J. 42 (6), 563\u2013645. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa554 (2021).","journal-title":"Eur. Heart J."},{"issue":"7","key":"1427_CR26","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/ejhf.2924","volume":"25","author":"M Greutmann","year":"2023","unstructured":"Greutmann, M. et al. SERVE investigators. Effect of phosphodiesterase-5 Inhibition on systemic right ventricular size and function. A multicentre, double-blind, randomized, placebo-controlled trial: SERVE. Eur. J. Heart Fail. 25 (7), 1105\u20131114. https:\/\/doi.org\/10.1002\/ejhf.2924 (2023).","journal-title":"Eur. J. Heart Fail."},{"issue":"1","key":"1427_CR27","doi-asserted-by":"publisher","first-page":"CD012621","DOI":"10.1002\/14651858.CD012621.pub2","volume":"1","author":"H Barnes","year":"2019","unstructured":"Barnes, H., Brown, Z., Burns, A. & Williams, T. Phosphodiesterase 5 inhibitors for pulmonary hypertension. Cochrane Database Syst. Rev. 1 (1), CD012621. https:\/\/doi.org\/10.1002\/14651858.CD012621.pub2 (2019).","journal-title":"Cochrane Database Syst. Rev."},{"issue":"23","key":"1427_CR28","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","volume":"316","author":"CONSENSUS Trial Study Group","year":"1987","unstructured":"CONSENSUS Trial Study Group. Effects of Enalapril on mortality in severe congestive heart failure. Results of the cooperative North Scandinavian Enalapril survival study (CONSENSUS). N Engl. J. Med. 316 (23), 1429\u20131435. https:\/\/doi.org\/10.1056\/NEJM198706043162301 (1987).","journal-title":"N Engl. J. Med."},{"issue":"Suppl 4","key":"1427_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2165\/00003495-199000394-00007","volume":"39","author":"K Chatterjee","year":"1990","unstructured":"Chatterjee, K. & De Marco, T. Systemic and coronary haemodynamics and pharmacodynamics of Enalapril and Enalaprilat in congestive heart failure. Drugs 39 (Suppl 4), 29\u201340. https:\/\/doi.org\/10.2165\/00003495-199000394-00007 (1990). discussion 41\u2009\u2013\u20092.","journal-title":"Drugs"},{"issue":"5","key":"1427_CR30","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1016\/j.jtcvs.2017.06.016","volume":"154","author":"S Wang","year":"2017","unstructured":"Wang, S. et al. A neonatal rat model of increased right ventricular afterload by pulmonary artery banding. J. Thorac. Cardiovasc. Surg. 154 (5), 1734\u20131739. https:\/\/doi.org\/10.1016\/j.jtcvs.2017.06.016 (2017).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"11","key":"1427_CR31","doi-asserted-by":"publisher","first-page":"e015574","DOI":"10.1161\/JAHA.119.015574","volume":"9","author":"L Ye","year":"2020","unstructured":"Ye, L. et al. Pressure overload greatly promotes neonatal right ventricular cardiomyocyte proliferation: A new model for the study of heart regeneration. J. Am. Heart Assoc. 9 (11), e015574. https:\/\/doi.org\/10.1161\/JAHA.119.015574 (2020).","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"1427_CR32","doi-asserted-by":"publisher","first-page":"5784","DOI":"10.1038\/s41467-021-25933-5","volume":"12","author":"X Liu","year":"2021","unstructured":"Liu, X. et al. Cell proliferation fate mapping reveals regional cardiomyocyte cell-cycle activity in subendocardial muscle of left ventricle. Nat. Commun. 12 (1), 5784. https:\/\/doi.org\/10.1038\/s41467-021-25933-5 (2021).","journal-title":"Nat. Commun."},{"key":"1427_CR33","doi-asserted-by":"publisher","first-page":"596960","DOI":"10.3389\/fcell.2020.596960","volume":"8","author":"X Ding","year":"2020","unstructured":"Ding, X. et al. Neonatal heart responds to pressure overload with differential alterations in various cardiomyocyte maturation programs that accommodate simultaneous hypertrophy and hyperplasia. Front. Cell. Dev. Biol. 8, 596960. https:\/\/doi.org\/10.3389\/fcell.2020.596960 (2020).","journal-title":"Front. Cell. Dev. Biol."},{"issue":"6","key":"1427_CR34","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1016\/j.jtcvs.2021.10.045","volume":"164","author":"GPL Bossers","year":"2022","unstructured":"Bossers, G. P. L. et al. Neuregulin-1 enhances cell-cycle activity, delays cardiac fibrosis, and improves cardiac performance in rat pups with right ventricular pressure load. J. Thorac. Cardiovasc. Surg. 164 (6), e493\u2013e510. https:\/\/doi.org\/10.1016\/j.jtcvs.2021.10.045 (2022). Epub 2021 Nov 3.","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"513","key":"1427_CR35","doi-asserted-by":"publisher","first-page":"eaaw6419","DOI":"10.1126\/scitranslmed.aaw6419","volume":"11","author":"H Liu","year":"2019","unstructured":"Liu, H. et al. Control of cytokinesis by \u03b2-adrenergic receptors indicates an approach for regulating cardiomyocyte endowment. Sci. Transl Med. 11 (513), eaaw6419. https:\/\/doi.org\/10.1126\/scitranslmed.aaw6419 (2019).","journal-title":"Sci. Transl Med."},{"issue":"3","key":"1427_CR36","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1056\/NEJMcibr1913824","volume":"382","author":"KE Yutzey","year":"2020","unstructured":"Yutzey, K. E. & Cytokinesis Beta-Blockers, and congenital heart disease. N Engl. J. Med. 382 (3), 291\u2013293. https:\/\/doi.org\/10.1056\/NEJMcibr1913824 (2020).","journal-title":"N Engl. J. Med."},{"issue":"9","key":"1427_CR37","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.3390\/cells11091386","volume":"11","author":"H Venugopal","year":"2022","unstructured":"Venugopal, H., Hanna, A., Humeres, C. & Frangogiannis, N. G. Properties and functions of fibroblasts and myofibroblasts in myocardial infarction. Cells 11 (9), 1386. https:\/\/doi.org\/10.3390\/cells11091386 (2022).","journal-title":"Cells"},{"issue":"7","key":"1427_CR38","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41569-021-00646-w","volume":"19","author":"NG Frangogiannis","year":"2022","unstructured":"Frangogiannis, N. G. Transforming growth factor-\u03b2 in myocardial disease. Nat. Rev. Cardiol. 19 (7), 435\u2013455. https:\/\/doi.org\/10.1038\/s41569-021-00646-w (2022).","journal-title":"Nat. Rev. Cardiol."},{"key":"1427_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.lfs.2017.02.016","volume":"174","author":"TT Zhu","year":"2017","unstructured":"Zhu, T. T. et al. LOX-1 promotes right ventricular hypertrophy in hypoxia-exposed rats. Life Sci. 174, 35\u201342. https:\/\/doi.org\/10.1016\/j.lfs.2017.02.016 (2017).","journal-title":"Life Sci."},{"issue":"22","key":"1427_CR40","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1016\/j.lfs.2005.10.021","volume":"78","author":"R Roncon-Albuquerque Jr","year":"2006","unstructured":"Roncon-Albuquerque, R. Jr et al. Acute changes of biventricular gene expression in volume and right ventricular pressure overload. Life Sci. 78 (22), 2633\u20132642. https:\/\/doi.org\/10.1016\/j.lfs.2005.10.021 (2006).","journal-title":"Life Sci."},{"issue":"15","key":"1427_CR41","doi-asserted-by":"publisher","first-page":"e016862","DOI":"10.1161\/JAHA.120.016862","volume":"9","author":"X Li","year":"2020","unstructured":"Li, X. et al. Extracellular superoxide dismutase is associated with left ventricular geometry and heart failure in patients with cardiovascular disease. J. Am. Heart Assoc. 9 (15), e016862. https:\/\/doi.org\/10.1161\/JAHA.120.016862 (2020).","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"1427_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1161\/HYPERTENSIONAHA.107.098186","volume":"51","author":"Z Lu","year":"2008","unstructured":"Lu, Z. et al. Extracellular superoxide dismutase deficiency exacerbates pressure overload-induced left ventricular hypertrophy and dysfunction. Hypertension 51 (1), 19\u201325. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.107.098186 (2008).","journal-title":"Hypertension"},{"key":"1427_CR43","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.actbio.2019.03.017","volume":"89","author":"CO Heras-Bautista","year":"2019","unstructured":"Heras-Bautista, C. O. et al. Cardiomyocytes facing fibrotic conditions re-express extracellular matrix transcripts. Acta Biomater. 89, 180\u2013192. https:\/\/doi.org\/10.1016\/j.actbio.2019.03.017 (2019).","journal-title":"Acta Biomater."},{"issue":"23","key":"1427_CR44","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1016\/j.jacc.2022.03.379","volume":"79","author":"A Ajoolabady","year":"2022","unstructured":"Ajoolabady, A., Nattel, S., Lip, G. Y. H. & Ren, J. Inflammasome signaling in atrial fibrillation: JACC State-of-the-Art review. J. Am. Coll. Cardiol. 79 (23), 2349\u20132366. https:\/\/doi.org\/10.1016\/j.jacc.2022.03.379 (2022).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"1427_CR45","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jacbts.2021.08.006","volume":"7","author":"MB Olsen","year":"2021","unstructured":"Olsen, M. B. et al. Targeting the inflammasome in cardiovascular disease. JACC Basic. Transl Sci. 7 (1), 84\u201398. https:\/\/doi.org\/10.1016\/j.jacbts.2021.08.006 (2021).","journal-title":"JACC Basic. Transl Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01427-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01427-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01427-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T15:16:12Z","timestamp":1747754172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01427-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1427"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-01427-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"2 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17525"}}